《亞洲股市》新西蘭及星馬港台股續升0.6%-0.9%跑贏 前者屢破頂
美股昨晚繼續全面向好,美國8月第五區製造業活動由多年高位急降至逾一年低遠差預期,但7月全美新屋銷量四個月來首升略超預期,輝瑞與BioNTech新冠疫苗正式獲准於美國全面使用後,投資者風險胃納持續升溫,且美企季績理想,以及近期積弱中概股大幅抽升,過半道指成份股也造好,波音、貼價續漲的雪佛龍、卡特彼勒、高盛及陶氏依次續升近1%-2%,但醫保護理股及零售股全面受壓,尤其是強生及沃爾瑪跌逾1%,拖累道指由曾漲109點,收窄至僅升30點或0.1%收35,366;微軟由紀錄高位回吐0.7%,但fb、Alphabet、亞馬遜、藍籌英特爾與思科依次續升0.6%-1.3%,再度受散戶追捧熱炒「網紅股」AMC及GameStop急漲20%及27%,網上證券商Robinhood漲9%,連日跑贏屢破頂納指續升0.5%歷來首次突破萬五關;季績勝預期兼升全年盈測零售股百思買股價曾漲逾一成,收市升逾8%,受惠疫苗獲全面使用旅遊休閒股受捧,挪威郵輪升逾4.5%,憧憬澳門業務改善的永利度假村與拉斯維加斯金沙集團漲逾7%,標普續升近0.2%曾高見4,492連續第二天破頂。此外,富時及DAX逆區內升0.2%及0.3%三連漲;餘下歐洲主要股市反覆微吐。
美股期貨變動不大,呈好淡爭持。亞太區股市主要指數早段全面向好,但升幅均少於1%。美元兌日圓於亞洲升近0.2%於109.8,日經三連升,最高見27,897,現報27,834,升102點或近0.4%。台灣加權指數三連升,報16,953,續升0.8%。韓股繼昨天續升1.6%,今早高見3,161,現報3,144,續升0.2%。澳洲200三連彈,最高見7,542,現報7,524,升0.3%。新加坡海峽時報指數續升0.6%報3,125。吉隆坡綜合指數四連漲,承昨天高收漲2%勢,報1,563,續升0.6%。
新西蘭7月商品出口額按月降至57.5億紐元,進口額按月升至61.6億紐元。新西蘭50指數今早高見13,171屢創紀錄高,現報13,151,續升0.6%。
港股繼昨天高收續漲618點或近2.5%強勢,今早在昨天火車頭阿里巴巴(09988.HK)/藥明生物(02269.HK)/騰訊(00700.HK)/美團(03690.HK)/阿里健康(00241.HK)高開逾2.5%-4.5%主導,恆指高開202或0.8%,報25,930,最高見25,982,現報25,947,續升219點或近0.9%。
滬指及深成繼上周五續彈1.1%及0.8%,今早高開0.1%及低開近6點,報3,517及14,657,現報3,516及14,620,分別續升1點及回吐0.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.